Conversely, downregulation of NF-κB and TNF signaling pathways (Figure 3b)—typically involved in malignancy suppression during early carcinogenesis [35,36,37]—may diminish cellular defenses against tumorigenesis, thereby exacerbating cancer progression. The gene discussed is NFKB1; the disease is cancer.